The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
18F-fluorodeoxyglucose Positron Emission Tomography Influences Management Decisions in Patients with Biliary Cancer
Abstract
BACKGROUND: Although (18)F-fluorodeoxyglucose positron emission tomography (PET) has widespread clinical use, its role in cancers of the biliary tract is ill-defined. The aim of this study was to determine if preoperative PET provided additional staging information in patients with biliary tract cancer, beyond that obtained through conventional anatomic imaging. The role of PET in detecting disease recurrence after resection was also examined. STUDY DESIGN: Between March 2001 and October 2003, 126 patients with biopsy-proved or presumed biliary tract cancer (intrahepatic or extrahepatic cholangiocarcinoma and gallbladder carcinoma) underwent PET in addition to standard imaging evaluation. Histologic confirmation of the diagnosis was used as the reference standard with which PET results were compared. Patient followup information and serial imaging were reviewed for progression of lesions detected by PET. RESULTS: Of the 126 study patients, 93 (74%) underwent preoperative staging PET scans, the results of which changed the stage and treatment in 22 patients (24%): 15 of 62 (24%) with cholangiocarcinoma and 7 of 31 (23%) with gallbladder carcinoma. When used to assess for cancer recurrence (n=33), PET identified disease in 86% of patients but altered treatment in only 9%. So, of the entire study group, the findings of PET influenced management in 20% of patients (24% preoperative staging and 9% cancer recurrence). The sensitivity of PET for identifying the primary tumor was 80% overall: 78% for cholangiocarcinoma, 86% for gallbladder carcinoma. CONCLUSIONS: Most biliary tract cancers are (18)F-fluorodeoxyglucose avid tumors. In patients with potentially resectable tumors based on conventional imaging, PET identified occult metastatic disease and changed management in nearly one-fourth of all patients. PET also helped confirm recurrent cancer after resection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staging, Resectability, and Outcome in 225 Patients With Hilar Cholangiocarcinoma
Jarnagin, W. R., Fong, Y., DeMatteo, R. P., Gonen, M., Burke, E. C., Bodniewicz, J., Youssef, M., Klimstra, D., & Blumgart, L. H. (2001) · Annals of Surgery · doi:10.1097/00000658-200110000-00010 · Cited by 1,347
Self-citationBurke, E. C., Jarnagin, W. R., Hochwald, S. N., Pisters, P. W. T., Fong, Y., & Blumgart, L. H. (1998) · Annals of Surgery · doi:10.1097/00000658-199809000-00011 · Cited by 468
Self-citationLong-Term Results after Resection for Gallbladder Cancer: Implications for Staging and Management
Bartlett, D. L., Fong, Y., Fortner, J. G., Brennan, M. F., & Blumgart, L. H. (1996) · Annals of Surgery · doi:10.1097/00000658-199611000-00008 · Cited by 393
Self-citationFluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma
Anderson, C. D., Rice, M. H., Pinson, C. W., Chapman, W. C., Chari, R. S., & Delbeke, D. (2004) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2003.10.003 · Cited by 377
Kluge, R., Schmidt, F., Caca, K., Barthel, H., Hesse, S., Georgi, P., Seese, A., Huster, D., & Berr, F. (2001) · Hepatology · doi:10.1053/jhep.2001.23912 · Cited by 265
Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography
Keiding, S., Hansen, S. B., Rasmussen, H. H., Gee, A., Kruse, A., Roelsgaard, K., Tage-Jensen, U., & Dahlerup, J. F. (1998) · Hepatology · doi:10.1002/hep.510280316 · Cited by 210
Major Hepatic Resection for Hilar Cholangiocarcinoma: Analysis of 46 Patients
Rea, D. J. (2004) · Archives of Surgery · doi:10.1001/archsurg.139.5.514 · Cited by 202
FDG PET in the diagnosis of hilar cholangiocarcinoma
FRITSCHER-RAVENS, A., BOHUSLAVIZKI, K. H., BROERING, D. C., JENICKE, L., SCHÄFER, H., BUCHERT, R., ROGIERS, X., & CLAUSEN, M. (2001) · Nuclear Medicine Communications · doi:10.1097/00006231-200112000-00002 · Cited by 160
Clinical role of 18F-FDG PET for initial staging of patients with extrahepatic bile duct cancer
Kato, T., Tsukamoto, E., Kuge, Y., Katoh, C., Nambu, T., Nobuta, A., Kondo, S., Asaka, M., & Tamaki, N. (2002) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-0852-z · Cited by 117
Radical surgery for gallbladder cancer: current options
Muratore, A., Polastri, R., & Capussotti, L. (2000) · European Journal of Surgical Oncology · doi:10.1053/ejso.1999.0918 · Cited by 84
Jarnagin, W. R., Klimstra, D. S., Hezel, M. P., Gönen, M., Fong, Y., Roggin, K. K., Cymes, K., DeMatteo, R. P., D'Angelica, M. I., Blumgart, L. H., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.6631 · Cited by 78
Self-citationPositron emission tomography and cholangiocarcinoma in primary sclerosing cholangitis.
Widjaja, A., Mix, H., Wagner, S., Graz, K. F., Hoff, J. V. D., Petrich, T., Meier, P. N., & Manns, M. P. (1999) · PubMed · Cited by 14
Cited by
Benson, A. B., Abrams, T. A., Ben-Josef, E., Bloomston, P. M., Botha, J. F., Clary, B. M., Covey, A., Curley, S. A., D'Angelica, M. I., Davila, R., et al. (2009) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2009.0027 · Cited by 2,268
Self-citationGuidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
Bridgewater, J., Galle, P. R., Khan, S. A., Llovet, J. M., Park, J.-W., Patel, T., Pawlik, T. M., & Gores, G. J. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.01.021 · Cited by 1,511
Gallbladder cancer: epidemiology and outcome
Shaffer, E., & Hundal, R. (2014) · Clinical Epidemiology · doi:10.2147/clep.s37357 · Cited by 1,089
Clinical diagnosis and staging of cholangiocarcinoma
Blechacz, B., Komuta, M., Roskams, T., & Gores, G. J. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2011.131 · Cited by 747
Cholangiocarcinoma: Advances in pathogenesis, diagnosis, and treatment†
Blechacz, B., & Gores, G. J. (2008) · Hepatology · doi:10.1002/hep.22310 · Cited by 681
Metadata
- Authors
- Corvera, C. U., Blumgart, L. H., Akhurst, T., DeMatteo, R. P., D’Angelica, M., Fong, Y., & Jarnagin, W. R.
- Venue
- Journal of the American College of Surgeons
- Published
- 2008-01
- Volume
- 206
- Issue
- 1
- Pages
- 57-65
- ISSN
- 1072-7515 (ISSN-L)
- OpenAlex
- W2079892049
- Cited by
- 292
- References
- 12
- FWCI
- 14.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.